ClinicalTrials.govpublic full text
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma
asthma, eosinophilic asthma, pediatric patients, severe asthma, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 913451
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.